Other news to note for Feb. 11, 2020

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Alterity, Athenex, Aurigene Discovery, Beijing CC-Pharming, Bill & Melinda Gates Foundation, Bridge Biotherapeutics, China Grand, Clover, Curis, Ibio, Oncosec, Porton Pharma Solutions, Q Biomed, Recce.

Financings for Feb. 11, 2020

Biopharmas in Asia-Pacific raising money in public or private financings, including: Astellas Pharma, Ikarovec.

Earnings for Feb. 11, 2020

Quarterly snapshots from biopharma companies with marketed products, including: Seattle Genetics, Takeda Pharmaceutical.

Regulatory front for Feb. 11, 2020

The latest global regulatory news, changes and updates affecting biopharma, including: Aurolife, CDC, Central Drugs Standard Control Organisation, FDA, Glaxosmithkline, National Institute of Allergy and Infectious Diseases, Sanofi, U.S. Court of Appeals, World Health Organization.

Clinical data for Feb. 4-10, 2020

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Zai Lab.

Regulatory actions for Feb. 4-10, 2020

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Aptorum, Biocryst, Zai Lab.

No Comments